Registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France
French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
This study is collecting information from adults in France who have recently been diagnosed with immune thrombocytopenia or autoimmune hemolytic anemia to better understand these conditions and how well different treatments work in real life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Drugs / interventions | FOSFAMATINIB |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT02877706 on ClinicalTrials.gov |
What this trial studies
The CARMEN registry is a national observational study that collects data on adult patients newly diagnosed with Immune Thrombocytopenia (ITP) or Autoimmune Hemolytic Anemia (AIHA) in France. It aims to describe the clinical features of these conditions, evaluate the real-world risk-benefit ratio of various treatments, and assess adherence to management guidelines. By gathering comprehensive data, the registry seeks to improve understanding and management of ITP and AIHA in clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults aged 18 and older who have recently been diagnosed with ITP or AIHA.
Not a fit: Patients who oppose data collection will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance treatment strategies and outcomes for patients with ITP and AIHA.
How similar studies have performed: Similar registries have shown success in improving patient outcomes and treatment adherence in other conditions, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients (18+ year-old) * newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB Exclusion criteria: \- opposition to data collection
Where this trial is running
Toulouse
- Service de Médecine Interne — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Moulis Guillaume, MD PhD — University Hopsital Toulouse
- Study coordinator: Moulis Guillaume, MD PhD
- Email: moulis.g@chu-toulouse.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.